Keyphrases
Down Syndrome
100%
Treatment Protocol
23%
Leukemia
23%
Lymphoblast
23%
Children with Down Syndrome
23%
Myeloid Leukemia
15%
Dose Reduction
15%
Down Syndrome children
15%
Netherlands
7%
Chemotherapy
7%
Acute Lymphoblastic Leukemia
7%
Clinical Characteristics
7%
Surveillance Protocol
7%
Patient Experience
7%
Improved Outcomes
7%
Biological Characteristics
7%
Early Treatment
7%
Disease Entity
7%
Preleukemic
7%
Clinical Biology
7%
Acute Myeloid
7%
Severe Symptoms
7%
Cytostatic Therapy
7%
Transient Leukemia
7%
Sensitivity to Chemotherapy
7%
Immunology and Microbiology
Myeloid
100%
Lymphoblast
100%
Drug Dose Reduction
66%
Medicine and Dentistry
Down Syndrome
100%
Leukemia
16%
Lymphoblast
16%
Myeloid Leukemia
11%
Drug Dose Reduction
11%
Chemotherapy
11%
Disease
5%
Acute Lymphoblastic Leukemia
5%
Patient Experience
5%
Acute Myelogenous Leukemia
5%
Side Effect
5%
Leukemia in Children
5%
Neonatal Infant
5%
Cytostatic Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Down Syndrome
100%
Leukemia
16%
Chemotherapy
11%
Myeloid Leukemia
11%
Disease
5%
Acute Lymphoblastic Leukemia
5%
Side Effect
5%
Cytostatic Agent
5%
Biochemistry, Genetics and Molecular Biology
Down Syndrome
100%
Myeloid
16%
Lymphoblast
16%
Drug Dose Reduction
11%